References in Tuberculosis PDF file by sammyc2007


									What’s New in Tuberculosis?
A 20 minute Tour… Ricardo J. Gonzalez-Rothi, M.D.
REFERENCES 1. Prevention and Treatment of Tuberculosis Among Patients Infected With Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations, USDHS, Centers for Disease Control and Prevention. MMWR Oct. 30, 1998/Vol 47/No RR-20. 2. Nakata K, Rom WN, Honda Y, et al. Myocobacterium tuberculosis Enhances Human Immunodeficiency Virus – 1 Replication in the Lung. Am. J. Respir. Crit. Care Med. 1997;155:996-1003. 3. Tam CM, Chan SL, Lam CW, et al. Rifapentine and Isoniazid in the Continuation Phase of Treating Pulmonary Tuberculosis. Am. J. Respir. Crit. Care Med. 1998;157:1726-1733. (See accompanying editorial pp 1705-1707) 1. Giosus S, Casarini M, Alemmano L, et al. Effects of Aerosolized Interferon _ in Patients with Pulmonary Tuberculosis. Am. J. Respir. Crit. Care Med 1998; 158:1156-1162. 5. Tramontana JM. Thalidomide Treatment Reduces Tumor Necrosis Factor Alpha Production and Enhances Weight Gain in Patients with Pulmonary Tuberculosis. Mol. Med 1995;4:384-397. 6. Conlon E, Maruca C, Macavei C, Stanford JL, et al. Immunotherapy with Mycobacterium Vaccae in the Treatment of Tuberculosis in Romania 2. Respir. Med. 1997;91(1):21-29. 7. Philipp WJ, Poulet S, Eizlmeier K, et al. An Integrated Map of the Genome of the Tubercle Bacillus, Mycobacterium Tuberculosis H37 Rv, and Comparison with Mycobacterium Leprae. Proc. Natl. Acad. Sci. USA 1996;93:3132-3137. 8. MTB Genome Web Address: HTTP://www. 9. Gonzalez-Rothi RJ. Examining the Biology of Tuberculosis. Current Opinion in Pulmonary 1998;4:154-156.

To top